Company · CIK 1849011
Apeiron Capital Investment Corp.
| CIK | 1849011 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-12-23 |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-257369 | 2021-06-24 | 2021-11-10 | 9 |
Filings
11| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2023-08-11 | RWWithdrawn | 333-271852 | 0001104659-23-090549 |
| 2021-11-10 | 424B4Final prospectus | 333-257369 | 0001104659-21-136972 |
| 2021-11-08 | EFFECTDeclared effective | 333-257369 | 9999999995-21-004236 |
| 2021-10-27 | S-1/AAmendment | 333-257369 | 0001104659-21-130539 |
| 2021-10-25 | S-1/AAmendment | 333-257369 | 0001104659-21-129161 |
| 2021-09-28 | S-1/AAmendment | 333-257369 | 0001104659-21-120326 |
| 2021-09-14 | S-1/AAmendment | 333-257369 | 0001104659-21-115562 |
| 2021-08-27 | S-1/AAmendment | 333-257369 | 0001104659-21-110645 |
| 2021-07-09 | S-1/AAmendment | 333-257369 | 0001104659-21-090679 |
| 2021-06-24 | S-1Registration filed | 333-257369 | 0001104659-21-085208 |
| 2021-03-15 | DRSDraft made public | 377-04421 | 0001104659-21-036335 |